292 related articles for article (PubMed ID: 30938616)
1. Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).
Elliott JW
J Am Vet Med Assoc; 2019 Apr; 254(8):960-966. PubMed ID: 30938616
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs.
Heaton CM; Fernandes AFA; Jark PC; Pan X
J Vet Intern Med; 2020 Mar; 34(2):873-881. PubMed ID: 31977135
[TBL] [Abstract][Full Text] [Related]
3. Palmar-plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report.
Kim E; Kim SS; Ryu MO
J Vet Sci; 2023 Nov; 24(6):e76. PubMed ID: 37904638
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
London C; Mathie T; Stingle N; Clifford C; Haney S; Klein MK; Beaver L; Vickery K; Vail DM; Hershey B; Ettinger S; Vaughan A; Alvarez F; Hillman L; Kiselow M; Thamm D; Higginbotham ML; Gauthier M; Krick E; Phillips B; Ladue T; Jones P; Bryan J; Gill V; Novasad A; Fulton L; Carreras J; McNeill C; Henry C; Gillings S
Vet Comp Oncol; 2012 Sep; 10(3):194-205. PubMed ID: 22236194
[TBL] [Abstract][Full Text] [Related]
5. Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs.
Yamazaki H; Tanaka T; Mie K; Nishida H; Miura N; Akiyoshi H
J Vet Intern Med; 2020 May; 34(3):1272-1281. PubMed ID: 32267594
[TBL] [Abstract][Full Text] [Related]
6. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
Musser ML; Johannes CM
BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
[TBL] [Abstract][Full Text] [Related]
7. Histopathological diagnosis and surgical complications following bilateral anal sacculectomy for the treatment of unilateral canine apocrine gland anal sac adenocarcinoma: 35 cases (2019-2023).
Franca A; Stamenova P; Thompson JL
J Small Anim Pract; 2024 Jun; 65(6):394-401. PubMed ID: 38594872
[TBL] [Abstract][Full Text] [Related]
8. Apocrine gland anal sac adenocarcinoma in cats: 30 cases (1994-2015).
Amsellem PM; Cavanaugh RP; Chou PY; Bacon NJ; Schallberger SP; Farese JP; Kuntz CA; Liptak JM; Culp WTN; Robat CS; Powers BE
J Am Vet Med Assoc; 2019 Mar; 254(6):716-722. PubMed ID: 30835176
[TBL] [Abstract][Full Text] [Related]
9. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
[TBL] [Abstract][Full Text] [Related]
10. Complications associated with iliosacral lymphadenectomy in dogs with metastatic apocrine gland anal sac adenocarcinoma.
Huerta Y; De Mello Souza CH; Selmic LE; McGrath A; Skinner OT; Dark KV; Traverson M; Snell WL; Maxwell EA; Bertran J; Hasiuk MMM
Can Vet J; 2022 Sep; 63(9):929-934. PubMed ID: 36060485
[TBL] [Abstract][Full Text] [Related]
11. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
Wouda RM; Hocker SE; Higginbotham ML
Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
[TBL] [Abstract][Full Text] [Related]
12. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005-2011).
Potanas CP; Padgett S; Gamblin RM
J Am Vet Med Assoc; 2015 Apr; 246(8):877-84. PubMed ID: 25835172
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995).
Williams LE; Gliatto JM; Dodge RK; Johnson JL; Gamblin RM; Thamm DH; Lana SE; Szymkowski M; Moore AS;
J Am Vet Med Assoc; 2003 Sep; 223(6):825-31. PubMed ID: 14507100
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methods to determine primary tumour size in canine apocrine gland anal sac adenocarcinoma.
Schlag AN; Johnson T; Vinayak A; Kuvaldina A; Skinner OT; Wustefeld-Janssens BG
J Small Anim Pract; 2020 Mar; 61(3):185-189. PubMed ID: 31960434
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma.
Griffin MA; Mayhew PD; Culp WTN; Giuffrida MA; Telek S; Singh A; Oblak M; Swanton E
J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37225157
[TBL] [Abstract][Full Text] [Related]
16. Clinical hypocalcemia following surgical resection of apocrine gland anal- sac adenocarcinomas in 3 dogs.
Olsen JA; Sumner JP
Can Vet J; 2019 Jun; 60(6):591-595. PubMed ID: 31156257
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of electrochemotherapy in the management of apocrine gland anal sac adenocarcinomas in dogs: A retrospective study.
Valenti P; Menicagli F; Baldi A; Barella G; Catalucci C; Attorri V; Spugnini EP
Open Vet J; 2021; 11(1):100-106. PubMed ID: 33898290
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
Urie BK; Russell DS; Kisseberth WC; London CA
BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999-2013).
McQuown B; Keyerleber MA; Rosen K; McEntee MC; Burgess KE
Vet Comp Oncol; 2017 Sep; 15(3):840-851. PubMed ID: 26991552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
